Peripheral venous congestion causes time- and dose-dependent release of endothelin-1 in humans

Document Type

Article

Publication Date

3-1-2017

Publication Title

Physiol Rep

Abstract

Endothelin-1 (ET-1) is a pivotal mediator of vasoconstriction and inflammation in congestive states such as heart failure (HF) and chronic kidney disease (CKD). Whether peripheral venous congestion (VC) increases plasma ET-1 at pressures commonly seen in HF and CKD patients is unknown. We seek to characterize whether peripheral VC promotes time- and dose-dependent increases in plasma ET-1 and whether these changes are sustained after decongestion. We used a randomized, cross-over design in 20 healthy subjects (age 30 ± 7 years). To experimentally model VC, venous pressure was increased to either 15 or 30 mmHg (randomized at first visit) above baseline by inflating a cuff around the subject's dominant arm; the nondominant arm served as a noncongested control. We measured plasma ET-1 at baseline, after 20, 60 and 120 min of VC, and finally at 180 min (60 min after cuff release and decongestion). Plasma ET-1 progressively and significantly increased over 120 min in the congested arm relative to the control arm and to baseline values. This effect was dose-dependent: ET-1 increased by 45% and 100% at VC doses of 15 and 30 mmHg, respectively (

Comments

© authors, original version available at: 10.14814/phy2.13118

Creative Commons Attribution License

Medical Subject Headings

Adult; Cross-Over Studies; Endothelin-1; Female; Humans; Male; Time Factors; Vasoconstriction; Venous Pressure; Young Adult

PubMed ID

28320895

Volume

5

Issue

6

Find It @ Sladen

Share

COinS